Skip to main content
Livermore
Livermore
ZHEN

Cencora, Inc.

COR
Exchange
NYSE
Industry
Wholesale-Drugs, Proprietaries & Druggists' Sundries
SEC CIK
0001140859

In the last 90 days, Cencora, Inc. insiders filed 0 open-market purchases and 3 sales; 1,352 institutions reported holding it in 13F filings for Q2 2026, worth $51.8B in total; no superinvestor holds it.

Holders of 5% or more of COR

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Cencora, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of COR
HolderLatest formStakeChangeFirst filedLatest filingFiling
BlackRock, Inc.13G/A8.50%16.4M shares–Jan 31, 20251 filingJan 31, 2025SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

5 Schedule 13D and 13G filings on Cencora, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on COR
Filed (ET)FilerFormStakeChangeEvent dateFiling
Jul 29, 202511:23 AM ETVanguard Group Inc13G/A11.59%22.5M shares–Jun 30, 2025SEC
Jun 9, 20255:16 PM ETWalgreens Boots Alliance, Inc.and 2 others13D/A4.96%9.62M shares−0.44 ppfrom 5.40%Below 5%Jun 9, 2025SEC
May 28, 20255:00 PM ETWalgreens Boots Alliance, Inc.and 2 others13D/A5.40%10.4M shares0.00 ppfrom 5.40%May 27, 2025SEC
Mar 25, 20254:34 PM ETWalgreens Boots Alliance, Inc.and 2 others13D/A5.40%10.4M shares−1.10 ppfrom 6.50%Mar 21, 2025SEC
Feb 10, 20257:54 PM ETWalgreens Boots Alliance, Inc.and 2 others13D/A6.50%12.6M shares–Feb 6, 2025SEC
Jan 31, 20253:59 PM ETBlackRock, Inc.13G/A8.50%16.4M shares–Dec 31, 2024SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Cencora, Inc. shares.

No Form 144 notices for Cencora, Inc. are on file.